BNGO 8-K 2026-11-10

Bionano Genomics, Inc. (BNGO) 8-K dated 2026-11-10 — accession 0001411690-26-000058.

Bionano Genomics, Inc. (BNGO) is a medical instruments & supplies company listed on US.

Bionano Genomics, Inc. filed a 8-K on 2026-11-10. Accession 0001411690-26-000058.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BNGO revenue for 2025-12-31 was $28.5M. Net income was -$26.4M. Revenue was down 7.4% from 2024-12-31 to 2025-12-31. BNGO currently screens at market cap $13.4M.

Not investment advice. The BNGO SEC hub lists recent forms. The stock page is the research view.